1. Home
  2. AHH vs ADPT Comparison

AHH vs ADPT Comparison

Compare AHH & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • ADPT
  • Stock Information
  • Founded
  • AHH 1979
  • ADPT 2009
  • Country
  • AHH United States
  • ADPT United States
  • Employees
  • AHH N/A
  • ADPT N/A
  • Industry
  • AHH Real Estate
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AHH Finance
  • ADPT Health Care
  • Exchange
  • AHH Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • AHH 821.2M
  • ADPT 929.8M
  • IPO Year
  • AHH 2013
  • ADPT 2019
  • Fundamental
  • Price
  • AHH $9.95
  • ADPT $7.45
  • Analyst Decision
  • AHH Buy
  • ADPT Buy
  • Analyst Count
  • AHH 2
  • ADPT 4
  • Target Price
  • AHH $11.88
  • ADPT $6.75
  • AVG Volume (30 Days)
  • AHH 1.0M
  • ADPT 1.3M
  • Earning Date
  • AHH 02-20-2025
  • ADPT 02-12-2025
  • Dividend Yield
  • AHH 8.24%
  • ADPT N/A
  • EPS Growth
  • AHH N/A
  • ADPT N/A
  • EPS
  • AHH N/A
  • ADPT N/A
  • Revenue
  • AHH $756,903,000.00
  • ADPT $177,282,000.00
  • Revenue This Year
  • AHH N/A
  • ADPT $6.48
  • Revenue Next Year
  • AHH $5.79
  • ADPT $18.72
  • P/E Ratio
  • AHH N/A
  • ADPT N/A
  • Revenue Growth
  • AHH 19.33
  • ADPT N/A
  • 52 Week Low
  • AHH $9.26
  • ADPT $2.28
  • 52 Week High
  • AHH $12.46
  • ADPT $7.50
  • Technical
  • Relative Strength Index (RSI)
  • AHH 44.90
  • ADPT 61.48
  • Support Level
  • AHH $9.26
  • ADPT $5.98
  • Resistance Level
  • AHH $10.27
  • ADPT $7.28
  • Average True Range (ATR)
  • AHH 0.23
  • ADPT 0.56
  • MACD
  • AHH 0.02
  • ADPT 0.04
  • Stochastic Oscillator
  • AHH 68.32
  • ADPT 96.86

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. They lease our properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting and real estate services. It generates maximum revenue from the general contracting and real estate services segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: